CLINICAL_TRIALS
trial_result
· 2021-03-01
Clinical Trial Update: A Study of Bumetanide for the Treatment of Autism Spectrum Disorders [Phase 2]
Summary
Phase 2 clinical trial investigating bumetanide for autism spectrum disorders has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED